UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Medline ® Abstract for Reference 12

of 'Treatment of relapsed or refractory mantle cell lymphoma'

12
TI
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study
AU
Dreyling M,Jurczak W,Jerkeman M,Silva RS,Rusconi C
SO
Lancet. 2015;
 
AD